Aktiengesellschaft Bayer Century Therapeutics, Inc. (IPSC) insider trading activity

Aktiengesellschaft Bayer is > 10% Shareholder of Century Therapeutics, Inc.. Currently has a direct ownership of 12.7 Million shares of IPSC, which is worth approximately $13.9 Million. The most recent transaction as insider was on Jun 22, 2021, when has been sold 750,000 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $15,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7M

0% 3M change

0% 12M change

Total Value Held $13.9 Million

AKTIENGESELLSCHAFT BAYER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 22 2021	BUY Open market or private purchase	$15,000,000 $20.0 p/Share	750,000 Added 5.59%	12,675,838 Common Stock
Jun 22 2021	BUY Conversion of derivative security	-	11,925,838 Added 50.0%	11,925,838 Common Stock

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

> 10% Shareholder

ELAN

Elanco Animal Health Inc Healthcare

> 10% Shareholder